| Source: | Fusarium moniliforme |
| Synonyms | |
| Description: | Structural analog of Fumonisin B1. Fumonisin B2 is more cytotoxic than Fumonisin B1. Fumonisin B2 inhibits sphingosine acyl-transterase. |
| CAS number: | 116355-84-1 |
| Merck index: | 13:4310 （Fumonisin） |
| Molecular weight: | 705.8 |
| Structure: | 
|
| Molecular Formula: | C34H59NO14 |
Solubility
information: | Methanol |
| Specifications | |
| Appearance: | Off-white solid. |
| Purity | Not less than 96% by TLC. At least 98% by HPLC |
| lmax: | |
| Melting point | |
| Solubility | |
| Storage | +4°C. Protect from light. |
| Applications | |
| Warnings | Carcinogen |
| Classification | isoflavonoid
Phytoestrogen.
sphingosine acyl-transteraseinhibitor |
| Related products |
|
| | For Research use only. Not for Human or Drug use
GMP/API grade available on request
Fumonisin B2 by Fermentek is not produced from or contains any ingredients from animal origin.
No genetically modified organisms are used. |
| Publications | Turner PC, Nikiema P, Wild CP.
Fumonisin contamination of food: progress in development of biomarkers to better assess human health risks.
Mutat Res. 1999 Jul 15;443（1-2）:81-93. Review. |
| | Bucci TJ, Howard PC, Tolleson WH, Laborde JB, Hansen DK.
Renal effects of fumonisin mycotoxins in animals.
Toxicol Pathol. 1998 Jan-Feb;26（1）:160-4. Review |
| | Shephard GS.
Chromatographic determination of the fumonisin mycotoxins.
J Chromatogr A. 1998 Jul 31;815（1）:31-9. Review. |
| | Desai K, Sullards MC, Allegood J, Wang E, Schmelz EM, Hartl M, Humpf HU, Liotta DC, Peng Q, Merrill AH Jr.
Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis.
Biochim Biophys Acta. 2002 Dec 30;1585（2-3）:188-92 |
| | Duvick J.
Prospects for reducing fumonisin contamination of maize through genetic modification.
Environ Health Perspect. 2001 May;109 Suppl 2:337-42. Review. |
| | Miller JD.
Factors that affect the occurrence of fumonisin.
Environ Health Perspect. 2001 May;109 Suppl 2:321-4. Review |
